Delivery Order SPE2DB20D3303-SPE2DB24FA1XC

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Serevent Diskus 50 mcg 60s, a prescription medication, with a ceiling value of $2,193.35 and a period of performance through April 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Serevent Diskus 50 mcg, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $1,360.80 and an ultimate completion date of August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Serevent Diskus 50 MCG 60S, a prescription medication, with a ceiling value of $2,058.56 and a performance period ending on June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,295,253 units of Serevent Diskus 50 MCG 60S, a prescription medication. The contract has an ultimate completion date of July 31, 2024 and a ceiling value of $2,302.97. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Serevent Diskus 50 mcg 60s, a respiratory medication. The contract has a ceiling value of $1,202.88 and is a firm fixed price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of Serevent Diskus 50 MCG 60S, a pharmaceutical product, and has a potential value of $1,692.65. The delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,508.67, is for the supply of Serevent Diskus 50 mcg 60s, a respiratory medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a $1,559.61 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of 4,565,164,927 units of the pharmaceutical product Serevent Diskus 50 MCG 60S. The award date is July 16, 2024 and the ultimate completion date is July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Serevent Diskus 50 MCG 60S, a pharmaceutical product. The contract has a ceiling value of $2,033.93 and a completion date of February 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corporation holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Serevent Diskus 50 MCG 60S, a respiratory medication. The contract has a firm fixed price of $1,147.32 and a completion date of June 4, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime contractor and has...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1XC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Serevent Diskus 50 mcg, a prescription medication, with a ceiling value of $4,292.85 and a performance period through August 9, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/7/24, 9:32 AM